All CIC members and non-members are invited to join us in attending the 2016 Mark Ernsting Drug Discovery Memorial Lecture. The inaugural Lecture is named in honour of Dr. Mark Ernsting, who was a Senior Biomedical Engineer in the Drug Discovery Program at OICR, but passed away in 2015. During his career, he strived to improve the lives and prognoses of cancer patients by developing nanomedicines designed to safely deliver more effective drugs that minimize toxicity.
Keynote speaker: Dr. Stuart L. Schreiber
Morris Loeb Professor
Director, Center for the Science of Therapeutics Broad Institute of MIT and Harvard
Title of talk: Chemistry towards novel mechanism-of-action (nMoA) compounds in therapeutics discovery
Date: September 22, 2016
Time: 3-5 p.m.
Location: The Great Hall, Hart House, University of Toronto
7 Hart House Circle, Toronto, Ontario M5S 3H3
For more information and to register for free: https://www.eventbrite.ca/e/mark-ernsting-drug-discovery-memorial-lecture-given-by-dr-stuart-schreiber-tickets-27005851228